http://bio2rdf.org/drugbank_resource:DB00413_DB01267_nanopub.RATCy6SeA2G3ZzirNFrI6sNMg8azCqnr9a_oUsvbupOV8#head http://bio2rdf.org/drugbank_resource:DB00413_DB01267_nanopub.RATCy6SeA2G3ZzirNFrI6sNMg8azCqnr9a_oUsvbupOV8 http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00413_DB01267_nanopub.RATCy6SeA2G3ZzirNFrI6sNMg8azCqnr9a_oUsvbupOV8#assertion http://bio2rdf.org/drugbank_resource:DB00413_DB01267_nanopub.RATCy6SeA2G3ZzirNFrI6sNMg8azCqnr9a_oUsvbupOV8 http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00413_DB01267_nanopub.RATCy6SeA2G3ZzirNFrI6sNMg8azCqnr9a_oUsvbupOV8#provenance http://bio2rdf.org/drugbank_resource:DB00413_DB01267_nanopub.RATCy6SeA2G3ZzirNFrI6sNMg8azCqnr9a_oUsvbupOV8 http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00413_DB01267_nanopub.RATCy6SeA2G3ZzirNFrI6sNMg8azCqnr9a_oUsvbupOV8#publicationInfo http://bio2rdf.org/drugbank_resource:DB00413_DB01267_nanopub.RATCy6SeA2G3ZzirNFrI6sNMg8azCqnr9a_oUsvbupOV8 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00413_DB01267_nanopub.RATCy6SeA2G3ZzirNFrI6sNMg8azCqnr9a_oUsvbupOV8#assertion http://bio2rdf.org/drugbank:DB00413 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00413_DB01267 http://bio2rdf.org/drugbank:DB01267 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00413_DB01267 http://bio2rdf.org/drugbank_resource:DB00413_DB01267 http://purl.org/dc/terms/identifier drugbank_resource:DB00413_DB01267 http://bio2rdf.org/drugbank_resource:DB00413_DB01267 http://purl.org/dc/terms/title DDI between Pramipexole and Paliperidone - The atypical antipsychotic agent, paliperidone, may decrease the therapeutic effect of the anti-Parkinson's agent, pramipexole. This interaction may be due to the dopamine antagonist properties of paliperidone. Consider an alternate antipsychotic in those with Parkinson's disease or consider using clozapine or quetiapine if an atypical antipsychotic is necessary. http://bio2rdf.org/drugbank_resource:DB00413_DB01267 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00413_DB01267 http://www.w3.org/2000/01/rdf-schema#label DDI between Pramipexole and Paliperidone - The atypical antipsychotic agent, paliperidone, may decrease the therapeutic effect of the anti-Parkinson's agent, pramipexole. This interaction may be due to the dopamine antagonist properties of paliperidone. Consider an alternate antipsychotic in those with Parkinson's disease or consider using clozapine or quetiapine if an atypical antipsychotic is necessary. [drugbank_resource:DB00413_DB01267] http://bio2rdf.org/drugbank_resource:DB00413_DB01267_nanopub.RATCy6SeA2G3ZzirNFrI6sNMg8azCqnr9a_oUsvbupOV8#provenance http://bio2rdf.org/drugbank_resource:DB00413_DB01267_nanopub.RATCy6SeA2G3ZzirNFrI6sNMg8azCqnr9a_oUsvbupOV8#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00413_DB01267_nanopub.RATCy6SeA2G3ZzirNFrI6sNMg8azCqnr9a_oUsvbupOV8#publicationInfo http://bio2rdf.org/drugbank_resource:DB00413_DB01267_nanopub.RATCy6SeA2G3ZzirNFrI6sNMg8azCqnr9a_oUsvbupOV8#signature.MC0CFGJ14IRLLg1K http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00413_DB01267_nanopub.RATCy6SeA2G3ZzirNFrI6sNMg8azCqnr9a_oUsvbupOV8#signature.MC0CFGJ14IRLLg1K http://purl.org/nanopub/x/hasSignature MC0CFGJ14IRLLg1KEbJZCXQ19N7DeI1FAhUAi+Fl+SND2VmJJaCGNf3U8J6GNao= http://bio2rdf.org/drugbank_resource:DB00413_DB01267_nanopub.RATCy6SeA2G3ZzirNFrI6sNMg8azCqnr9a_oUsvbupOV8#signature.MC0CFGJ14IRLLg1K http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00413_DB01267_nanopub.RATCy6SeA2G3ZzirNFrI6sNMg8azCqnr9a_oUsvbupOV8 http://purl.org/dc/terms/created 2018-03-30T11:12:58.888+02:00 http://bio2rdf.org/drugbank_resource:DB00413_DB01267_nanopub.RATCy6SeA2G3ZzirNFrI6sNMg8azCqnr9a_oUsvbupOV8 http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00413_DB01267_nanopub.RATCy6SeA2G3ZzirNFrI6sNMg8azCqnr9a_oUsvbupOV8 http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00413_DB01267_nanopub.RATCy6SeA2G3ZzirNFrI6sNMg8azCqnr9a_oUsvbupOV8#signature.MC0CFGJ14IRLLg1K http://bio2rdf.org/drugbank_resource:DB00413_DB01267_nanopub.RATCy6SeA2G3ZzirNFrI6sNMg8azCqnr9a_oUsvbupOV8 http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234